Wednesday, October 22, 2025

Wednesday, October 22, 2025

Organization Directory

Refine Your Search L

Type:

Filter by Org Type:

Filter By Name:


Trending

  1. 1 JANSSEN: U.S. FDA Approves New DARZALEX® (daratumumab)-Based Combination Regimen for Patients with Relapsed/Refractory Multiple Myeloma
FDA Health News